Cannabinoid receptors CB 1 and CB 2 are known to be expressed during the mediation of certain cancer growth . Including but not limited to the TRPV channel (Transient receptor potential cation channel subfamily V member 1) and GPCR55 (G-Protein Coupled receptor 55) , these other receptors are also expressed during the genesis of certain cancers and may play a role in the remediation of cancer . Several studies have shown anti-proliferative and proapoptotic properties of cannabinoids towards certain cancers in-vitro. Limited clinical studies on the treatment of pancreatic cancer with cannabinoids as antineoplastics have been conducted .